7 reports

  • Lixte Biotechnology Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Lixte Biotechnology Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017
  • Pharmaceutical
  • United States
  • Company
  • Deals & Alliance
  • Lixte Biotechnology Holdings, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017
  • Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Companies Involved in Therapeutics Development

Its phosphatase technology helps in development of novel pharmaceutical therapeutics.

  • Biotechnology
  • Pharmaceutical
  • United States
  • Product Initiative
  • Lixte Biotechnology Holdings, Inc.
  • Septic Shock - Products under Development by Companies
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2016

TAKEDA PHARMACEUTICAL COMPANY LIMITED Takeda Pharmaceutical Company Limited (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of

  • Pharmaceutical
  • Research And Development
  • United States
  • Product Initiative
  • Lixte Biotechnology Holdings, Inc.
  • Brain Ischemia - Products under Development by Companies
  • Brain Ischemia - Therapeutics under Development by Companies

SPECTRUM PHARMACEUTICALS, INC.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Lixte Biotechnology Holdings, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017
  • Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Companies Involved in Therapeutics Development

The company also offers compound re-profiling to find new uses for old pharmaceuticals.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Lixte Biotechnology Holdings, Inc.
  • SP-9 - DRUG PROFILE
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016

NOXXON PHARMA AG SEPTIC SHOCK - PIPELINE BY NOXXON PHARMA AG, H## 2016 OCTAPHARMA AG (OCTAPHARMA) IS A PHARMACEUTICAL COMPANY.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Lixte Biotechnology Holdings, Inc.
  • COHBAR INC

Taxus Cardium Pharmaceuticals Group Inc. announced that it has entered into a binding term sheet with Dr.

  • Cardiovascular Disease
  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • Lixte Biotechnology Holdings, Inc.